Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics

Author： Lane Hsien-Yuan Lee Cheng-Chun Liu Yi-Ching Chang Wen-Ho

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.2, 2005-03, pp. : 139-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dose Response and Atypical Antipsychotics in Schizophrenia

By Kinon B.J.

CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. : 597-616

Adis International

Access to resources Recommend Favorite

Role of Newer Atypical Antipsychotics in the Management of Treatment- Resistant Schizophrenia

By Emsley R.A.

CNS Drugs, Vol. 13, Iss. 6, 2000-06 ,pp. : 409-420

Adis International

Access to resources Recommend Favorite

Olanzapine v Risperidone: A Contrast Between Atypical Antipsychotics Concerning Control of Schizophrenia

Current Psychopharmacology, Vol. 5, Iss. 1, 2016-06 ,pp. : 28-34

Bentham Science Publishers

Access to resources Recommend Favorite

The new atypical antipsychotics: a review of pharmacoeconomic studies

By Revicki D.A.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 249-260

Informa Healthcare

Access to resources Recommend Favorite

Partial Dopamine Receptor Agonists as Newer Atypical Antipsychotics:Intrinsic Activity Appropriate for Treatment of Schizophrenic Patients

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 3, 2007-09 ,pp. : 156-165

Bentham Science Publishers

Access to resources Recommend Favorite